---
title: "Before the US stock market opened on Wednesday, Thermo Fisher's stock price rose slightly. According"
description: "Before the US stock market opened on Wednesday, Thermo Fisher's stock price rose slightly. According to reports, it is close to acquiring the clinical trial software company Clario for $10 billion. Th"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263302261.md"
published_at: "2025-10-29T13:21:15.000Z"
---

# Before the US stock market opened on Wednesday, Thermo Fisher's stock price rose slightly. According

> Before the US stock market opened on Wednesday, Thermo Fisher's stock price rose slightly. According to reports, it is close to acquiring the clinical trial software company Clario for $10 billion. This move aligns with Thermo Fisher's strategy to expand its capabilities in the field of clinical trial data management. The acquisition deal may be announced soon, but the terms may change

Before the market opened on Wednesday, Thermo Fisher's stock price rose slightly. According to reports, it is close to acquiring clinical trial software company Clario for $10 billion. This move aligns with Thermo Fisher's strategy to expand its capabilities in the field of clinical trial data management. The acquisition deal may be announced soon, but the terms may change

### Related Stocks

- [TMO.US - Thermo Fisher Scentific](https://longbridge.com/en/quote/TMO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| QXO, Apollo Global, Thermo Fisher Scientific And More On CNBC's 'Final Trades' | On CNBC's 'Halftime Report Final Trades', QXO, Inc. was highlighted as a top pick after its shares rose 4.4% to $27.07.  | [Link](https://longbridge.com/en/news/276125837.md) |
| Thermo Fisher Scientific Inc. $TMO Shares Sold by Parnassus Investments LLC | Parnassus Investments LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.3% in Q3, now holding 2,093 | [Link](https://longbridge.com/en/news/272152709.md) |
| Palantir CEO Alex Karp Outspends Mark Zuckerberg On Private Jet, Michael Burry Calls It 'Quite The Feat' | Palantir Technologies CEO Alex Karp's travel expenses have come under scrutiny from investor Michael Burry, who highligh | [Link](https://longbridge.com/en/news/276258020.md) |
| Thermo Fisher Scientific Highlights Strong 2025 Performance and Growth Strategy in New Presentation | Thermo Fisher Scientific Inc. presented its 2025 performance and growth strategy at the J.P. Morgan Healthcare Conferenc | [Link](https://longbridge.com/en/news/272437238.md) |
| Here's How Much $1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today | Investing $1000 in Thermo Fisher Scientific (NYSE:TMO) 15 years ago would now be worth $10,371.15, reflecting an annuali | [Link](https://longbridge.com/en/news/269880072.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.